Cancer Stem Cells Market to Accumulate a Valuation of USD 2.9 Billion by 2030, Advancing at a 11.2% CAGR | MarketDigits

The Global Cancer Stem Cells Market was valued USD 1.4 Billion in 2023 and projected to reach USD 2.9 Billion by 2030, growing at a CAGR of 11.2% during the forecast period of 2023-2030

Richmond, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to a research report "Cancer Stem Cells Market, by Mode of action (Targeted Cancer Stem Cell, Stem Cell-based Cancer Therapy {Autologous stem cell transplants, Allogeneic stem cell transplants}), Cancer forms (Breast cancer, Blood cancer, Lung cancer, Brain cancer, Colorectal cancer, Pancreatic cancer, Bladder cancer, Liver cancer, Others), End-use (Hospitals and surgical laboratories, Cell banks and tissue banks, Pharmaceutical and biomedical companies, Others) and Region - Global Forecast to 2030.

Global Cancer Stem Cells Market Report Scope:

Report Details
Market size value in 2023 USD 1.4 Billion
Market size value in 2030 USD 2.9 Billion
CAGR (2023-2030) 11.2%
Forecast Period 2023–2030
Historic Data 2019
Forecast Units Value (USD Million/USD Billion)
Segments Covered Mode of action, Cancer forms, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and RoW
  • AbbVie Inc.
  • Astellas Pharma Inc.
Sample of Companies Covered
  • Bayer AG
  • Bionomics
  • FUJIFILM Irvine Scientific.

Download the Sample -

TOC Covers in Depth & Breath on Cancer Stem Cells Market
170 - Market Data Tables
65 - List of Figures
225 – Pages

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.

Market Overview

The Cancer Stem Cells (CSCs) market is rapidly rising within the expansive domain of oncology. Cancer stem cells exhibit self-renewal capabilities and the potential for diverse cell differentiation, contributing significantly to tumor growth, heterogeneity, and therapeutic resistance. This market has gathered considerable attention as researchers and pharmaceutical entities explore innovative strategies to effectively target and eliminate these resilient cells to address cancer initiation, progression, and recurrence. The market is characterized by ongoing research and development activities focused on identifying specific markers and pathways associated with cancer stem cells, thereby facilitating the creation of targeted therapeutic interventions. Advances in genomics, proteomics, and imaging technologies have deepened our understanding of CSC biology, raising the development of revolutionary treatment approaches. Collaborations between academic institutions, biotechnology firms, and pharmaceutical companies are developing a cooperative environment to accelerate the translation of CSC research findings into clinically applicable therapies. The global cancer stem cell market is driven by the increasing prevalence of diverse cancers, a progressively aging population, and heightened awareness regarding the key role played by CSCs in cancer progression. With the rise of personalized medicine, there is a growing demand for targeted therapies that specifically address the distinctive characteristics of cancer stem cells, positioning the market as a key influencer in shaping the future of oncological therapeutics even though the inherent challenges in identifying and targeting CSCs.

Major Vendors in the Global Cancer Stem Cells Market:

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Bionomics
  • FUJIFILM Irvine Scientific.
  • Lonza
  • MacroGenics, Inc
  • Merck KGaA
  • Miltenyi Biotec
  • PromoCell GmbH
  • ReNeuron Group plc
  • Sino Biological, Inc.
  • STEMCELL Technologies
  • Thermo Fisher Scientific Inc.

Request for Discount @

Technological Advancements In Genomics And Imaging Techniques

One of the primary drivers for the global cancer stem cell market is the technological advancements in genomics and imaging techniques. The ongoing evolution of genomic tools has empowered researchers to gain unparalleled insights into the molecular technicalities of cancer, enabling a more intense comprehension of the distinct features and behaviors exhibited by cancer stem cells. High-throughput sequencing and omics methodologies enable the identification of specific genetic markers linked to CSCs, covering the way for the targeted development of therapeutics. Simultaneously, breakthroughs in imaging techniques have revolutionized researcher's ability to visualize and monitor Cancer Stem Cells in real time within living organisms. Cutting-edge modalities such as positron emission tomography (PET), magnetic resonance imaging (MRI), and fluorescence microscopy provide non-invasive means to track CSC behavior, distribution, and responses to treatments. This capability is instrumental for studying CSC dynamics in their natural microenvironment and evaluating the effectiveness of therapeutic interventions.

Market Dynamics


  • Collaborations between pharmaceutical companies and research institutions
  • Rising global cancer incidence rates
  • Technological advancements in genomics and imaging techniques


  • Advances in precision medicine technologies
  • Increasing awareness of the role of Cancer Stem Cells
  • Growing investments in biotechnology and oncology research
  • Expanding applications of stem cell therapies

Expanding Applications Of Stem Cell Therapies

The expanding applications of stem cell therapies constitute a significant opportunity for the cancer stem cells (CSCs) market. Stem cells, known for their remarkable capacity to differentiate into diverse cell types, are increasingly recognized for their therapeutic potential in attempting cancer stem cells. As regenerative medicine continues to advance, researchers are actively exploring the utilization of various stem cells, including mesenchymal and induced pluripotent stem cells, to effectively target and obstruct the growth of cancer stem cells. Stem cell therapies provide a comprehensive approach by not only directly addressing CSCs but also by raising tissue repair and regeneration, modifying the harmful effects associated with cancer and conventional treatments. The regenerative capabilities of stem cells offer promise in overcoming challenges related to CSC heterogeneity and treatment resistance. The expanding scope of stem cell applications in cancer therapy signifies a transformative opportunity for the CSCs market, leading in innovative and general treatment modalities composed to revolutionize cancer management. As research advances, the incorporation of stem cell therapies into cancer treatment strategies represents a standard shift, holding the potential to raise patient outcomes and contribute to the development of revolutionary approaches in the fight against cancer.

North America dominates the market for Cancer Stem Cells (CSCs).

In North America, the Cancer Stem Cells market has experienced significant growth, driven by research and development efforts, well-established healthcare infrastructure, and substantial healthcare expenditure. The region's commitment to technological advancements, particularly in genomics and personalized medicine, has fueled initiatives to comprehensively understand and target Cancer Stem Cells. Collaborative ventures among pharmaceutical firms, academic institutions, and research organizations have accelerated the speed of innovation, facilitating the development of promising therapeutic approaches. North America's dominant position in the Cancer Stem Cells market is further supported by the increasing incidence of cancer cases and a proactive regulatory landscape encouraging the exploration of novel treatment modalities.

Asia Pacific region is observing prominent expansion in the cancer stem cells market, driven by a growing cancer burden, improving healthcare infrastructure, and increased investments in biotechnology and life sciences. Countries like China, Japan, and India are actively engaged in cancer research, experiencing a rise in initiatives dedicated to unraveling the complexities of cancer stem cells. The region's vast and diverse population provides an extensive area for clinical trials and research studies, attracting global pharmaceutical companies. With heightened awareness regarding the role of cancer stem cells in cancer progression, Asia Pacific is emerging as a key player in the global cancer stem cells market, presenting opportunities for collaborative efforts and market expansion.

Inquire Before Buying:

The Autologous Stem Cell Transplants Segment is anticipated to hold the Largest Market Share during the Forecast Period

In the global cancer stem cells market, the mode of action segment comprises various categories such as targeted cancer stem cell, and stem cell-based cancer therapy. Stem cell-based cancer therapy consists of Autologous Stem Cell Transplants and allogeneic Stem Cell Transplants. Autologous Stem Cell Transplants, a crucial category in the cancer stem cells market, represent an advanced therapeutic modality in the fight against cancer. This advanced procedure involves harvesting a patient's own stem cells, typically from bone marrow or peripheral blood, purifying them, and then reintroducing them into the same individual. The basis behind autologous stem cell transplants lies in their capacity to regenerate and restore damaged or diseased tissues, providing a personalized and focused treatment approach for various cancer types. Ongoing research and clinical advancements in this segment are contributing to the development of cancer treatment methodologies. Potential advantages include a lower risk of graft rejection, reduced complications associated with allogeneic transplants, and improved therapeutic outcomes. In the dynamic area of the cancer stem cells market, the Autologous Stem Cell Transplants segment occurs as a transformative avenue, helping in a new era of precision medicine and offering renewed optimism for individuals facing diverse cancer forms.

Segmentations Analysis of Cancer Stem Cells Market: -

  • By Mode of action
    • Targeted Cancer Stem Cell
    • Stem Cell-based Cancer Therapy
      • Autologous Stem Cell Transplants
      • Allogeneic Stem Cell Transplants
  • By Cancer Forms
    • Breast Cancer
    • Blood Cancer
    • Lung Cancer
    • Brain Cancer
    • Colorectal Cancer
    • Pancreatic Cancer
    • Bladder Cancer
    • Liver Cancer
    • Others
  • By End-Use
    • Hospitals And Surgical Laboratories
    • Cell Banks And Tissue Banks
    • Pharmaceutical And Biomedical Companies
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights @

Browse Similar Reports:

Cancer Biomarkers Market 2023 – 2030 by Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Type (Protein, Genetic), Application (Diagnostics, R&D, Prognostics), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics) - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Lung Cancer Screening Software Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Cancer Supportive Care Drugs Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us:
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Follow Us on: | Twitter | LinkedIn |